WEREWOLF THERAPEUTICS, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • May 10th, 2022 • Werewolf Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2022 Company Industry JurisdictionWerewolf Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Securities LLC (the “Agent”), as follows: